knowledge -WSS

knowledge

author：explore 2025-09-02 05:54:49 - browse：39815

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Trump indictment: Who are the 'co

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

How corporate America is slashing DEI workers amid backlash to diversity programs

What to know about a major upcoming Wegovy heart health study

What to know about a major upcoming Wegovy heart health study

North Korean leader's powerful sister says warplanes repelled US spy plane

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

knowledge

knowledge

hotspot

Guidelines to prevent youth baseball injuries need more muscle

What to know about a major upcoming Wegovy heart health study

Bright Health sells Medicare Advantage business to Molina

Mitch McConnell episode has important public health takeaway

Alkermes shareholders re

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

BioMarin wins approval for gene therapy to treat hemophilia A

NIH launches clinical trials and new research office for long Covid

After affirmative action ruling, medical educators look to 'holistic review'

UPS workers' union leader explains what's at stake as strike edges closer

leisure time

Rare Northern Lights show in US this week: Where and how to see it

How redistricting in 6 states could affect who controls Congress

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

House panel to mark up pandemic

‘Oppenheimer’ and the risks of AI in health care

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

focus

entertainment

focus

entertainment